Patient Preferences in Neuromuscular Diseases: Insights for Future Drug Development. [PDF]
ABSTRACT Incorporating patient preferences into drug development is crucial, particularly, for rare diseases with significant unmet needs. This study used Best‐Worst Scaling type 2 (BWS‐2) to explore benefit–risk trade‐offs for patients and caregivers in two rare neuromuscular diseases (NMDs), myotonic dystrophy type 1 (DM1), and mitochondrial myopathy
Jimenez-Moreno AC +10 more
europepmc +2 more sources
Prevalence of presbyopia among social safety net beneficiaries with the cognitive, numeracy and dexterity skills required for smartphone use: a cross-sectional analysis of THRIFT RCT screening data from Kurigram, Bangladesh. [PDF]
Aftab IB +19 more
europepmc +1 more source
Measuring adolescent health literacy in Nigeria: psychometric validation of the health literacy assessment scale for adolescents. [PDF]
Fehintola FO +4 more
europepmc +1 more source
Exploring Interrelationships Among Numeracy, Cancer Risk Perceptions, and Tobacco Product Use. [PDF]
Diaz D +6 more
europepmc +1 more source
Numeracy and pathological anxiety: the role of numerical and probabilistic reasoning in risk distortion. [PDF]
Quiles JRG, Schubert FT, Schmidt NB.
europepmc +1 more source
The genetic lottery goes to school: Better schools compensate for the effects of students' genetic differences. [PDF]
Cheesman R +3 more
europepmc +1 more source
Mitigating the impact of preterm birth on education and experience in schools. [PDF]
Shandilya S.
europepmc +1 more source
Health Literacy Mediates Racial Differences in Cognitive Functioning among African American/Black and White People with and without HIV in the Deep South. [PDF]
Delgadillo JD +7 more
europepmc +1 more source
Predicting Child Development Across Literacy, Physical, Learning, and Social-Emotional Domains Using Supervised Machine Learning: A Cross-Sectional Study Based on MICS 2019 Bangladesh. [PDF]
Islam F +8 more
europepmc +1 more source
Alzheimer's Disease Clinical Trial Decision-Making Among Patients with Mild Cognitive Impairment and Their Study Partners. [PDF]
Cox CG +8 more
europepmc +1 more source

